PMCID: PMC4309183
Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimers disease animal model
BPC-157 has been associated with modulation of dopaminergic and serotonergic signaling pathways, both of which are essential for emotional balance, motivation, and cognitive processing
It is indicated for the treatment of Polyneuropathy of any origin such as Diabetic, Alcoholic or Toxic neuropathies, Neuritis, Neuralgia, Cervical Syndrome, Shoulder-arm syndrome, Lumbago, Sciatica, Mayalgia, Herpes Zoster, Trigeminal Neuralgia, Supportive treatment in facial paresis Dosage & Administration: Tablet: 1 to 3 tablets daily or as directed by the physician
Advanced injectable protocol Goal: Maximum efficacy, willing to inject, committed to comprehensive protocol
Peptides are long chains of amino acids with specific three-dimensional structures